Oxford Business Group (OBG) is set to launch a new report focusing on the impact of the Covid-19 pandemic on the health sector in Morocco. For the realization of this study, entitled “Morocco’s Health and Medical Response to Covid-19”, the economic intelligence and consulting firm collaborated with many renowned players in the Moroccan medical, paramedical and pharmaceutical sectors, namely LEMM, Sanofi , Pfizer, Bayer, Promamec and Lamatem.
This new study is part of a series of bespoke reports already published or currently being prepared by Oxford Business Group and its partners on the economic consequences of the Covid-19 crisis and joins other essential research tools , such as the Covid-19 Economic Impact Assessments, which in the form of articles and interviews offer an assessment by country of the economic impact of the health crisis, or the Covid-19 Response Report (CRR) a review of the response of governments and different economic sectors to Covid-19.
Illustrated with numerous graphics and presented in a format highlighting the most relevant information, the report will combine analyzes, interviews and case studies of renowned companies in the health sector in Morocco.
The report “Morocco’s Health and Medical Response to Covid-19” will be composed of four parts: the first will give an overview of the health sector in Morocco and its evolution in recent years, whether it is the reform of the public hospital and health insurance, the weight of the private sector in the provision of care or the pharmaceutical sector. The second part will focus directly on the implications of Covid-19 on the health sector in Morocco, presenting the challenges that the health system has had to face and highlighting the assets that have enabled Morocco to best respond to the health crisis. The third part will be devoted to the industry’s response to the crisis. The fourth part will be forward-looking and will propose avenues for reinventing the health sector in Morocco and drawing lessons from the crisis.
Morocco has shown itself to be very responsive from the start of the Covid-19 crisis, quickly taking drastic measures to contain the pandemic. This strategy, combined with a relatively young population, avoided the high mortality that occurred in Europe in the spring. Thanks to a concerted mobilization of the public and private sectors, the kingdom was able to meet its pharmaceutical and medical needs.
The crisis, however, also revealed the difficulties that the Moroccan health system has faced for a long time, such as a shortage of human resources, a disparity between urban and rural areas and insufficient public spending. The report will review the new initiatives that have emerged since the start of the pandemic to respond to these difficulties and will highlight the driving areas for the future development of the sector.
“While Morocco has made significant progress in recent years in the area of health, particularly in terms of access to healthcare, the Covid-19 crisis has exposed the flaws in the system. The country will have to continue its efforts in the area of digitization and strengthen research and development in the sector,” said Souhir Mzali, Africa Editorial Director of OBG.